Prior studies in animals have indicated that the lymphatic system returns extravascular protein to the blood stream (1) (2) (3) (4) (5) (6) (7) (8) . Lewis injected horse serum subcutaneously into dogs and found that it appeared in the thoracic duct lymph before it was detected in the blood (4) . Similar observations were made by Field and Drinker (5) . Conklin, after injecting foreign proteins into the circulating blood of the frog, observed that they passed through the skin capillaries into the lymphatics (6) . More recently Courtice, Simmonds and Steinbeck have shown that homologous serum protein labeled with Evans blue is absorbed by the lymphatics when introduced into the pleural or peritoneal cavities (7, 8) .
In man, lymphatic function has been studied mainly by outlining the lymphatics visually with vital dyes injected into the tissues (9) (10) (11) . The interpretation of these studies has been based primarily on the local distribution of the dyes in the tissues. The removal of particles and colloids by the lymphatics also has been studied (12) (13) (14) . However, the results of these experiments have been influenced by the local reaction of the tissue to the injected foreign substance.
The present study was undertaken to determine whether the rate of disappearance of human serum albumin injected into the subcutaneous tissues might give some estimate of lymphatic function in man (15) . 
MATERIAL AND METHODS
Hospitalized patients with and without edema were studied. All patients had been at bed rest for 3 to 5 days without showing a variation in weight of more than 2 pounds or a measurable change in the size of the extremities. Throughout the study the patients remained at bed rest without significant change in body weight or in the circumference of the injected limb.
Fifteen patients in the control group had no history or physical findings suggesting cardiovascular or peripheral vascular disease. Their limbs were nonedematous and appeared normal.
Five patients had had lymphedema of an entire upper extremity for 3 to 15 weeks following radical mastectomy for carcinoma of the breast. One patient had had lymphedema of the lower extremity of 9 weeks' duration, resulting from a radical groin resection for malignant melanoma. In all 6 patients the edematous extremity pitted to local pressure. However, the venous pressure in the involved as well as in the opposite normal limb was in the normal range.
Seven patients had had edema, caused by peripheral venous obstruction, for 1 to Fifteen patients in severe congestive heart failure had enlargement of the heart, pulmonary congestion by X-ray, venous distention, marked pitting edema of the legs, elevated venous pressure and prolonged circulation time. The heart failure with peripheral edema had been present for 1 to 5 weeks and was being treated with salt restriction and maintenence of digitalis but without diuretics. Three patients with rheumatic heart disease, 2 with hypertensive heart disease and 1 with pulmonic stenosis were restudied after their edema had disappeared following further medical therapy with additional digitalis and frequent injections of mercurials. The hypertensive patients were also given antihypertensive drugs with return of their blood pressures close to normal 222 levels. One other patient with constrictive pericarditis was restudied after pericardectomy at which time he was fully compensated, as revealed by the findings of right heart catheterization.
Six patients with Laennec's cirrhosis and 4 patients with nephrotic syndrome had peripheral edema associated with hypoproteinemia. The edema of the legs was of 2 to 7 weeks' duration and pitted markedly. The nephrotic syndrome was caused by amyloidosis in 2 patients, intercapillary glomerulosclerosis in 1 other patient, and glomerulonephritis in the remaining patient. All the patients had a normal venous pressure and were receiving a diet restricted in salt.
Twenty to 30 ,uc of a 1 per cent solution of I"31-labeled human serum albumin 1 was administered subcutaneously into an extremity in a volume of 0.03 to 0.05 ml using a 25 gage needle and a tuberculin syringe. In all studies on paired extremities and in repeat studies in cardiac patients the dose and volume of labeled albumin inj ected into the limbs was identical. The sites of injection were similarly controlled. To prevent leakage of the radioactive protein from the puncture wound, the labeled albumin was injected 30 to 35 mm from the site of puncture by advancing the needle subcutaneously. After the needle was withdrawn the puncture site was sealed with collodion. The site of injection was then externally monitored at intervals of 10 to 15 minutes for the first hour and every 2 to 3 hours for the next 12 hours. Thereafter, the site was monitored 4 times a day until the injected radioactivity had disappeared from the limb. The activity at the site of injection was corrected for "background" by subtracting the radioactivity of the uninjected limb from the activity of the injected limb. In certain cases, a scintogram scan of the entire limb was made and compared with that of the opposite control limb. The thyroid gland was externally monitored at intervals of 6 to 12 hours. Daily total urine collections were made and assayed for radioactivity. Plasma samples were drawn at times at which the limb was monitored. Total radioactivity, trichloroacetic acid (10 per cent) precipitable radioactivity, and the radioactivity in the supernatant were determined in the plasma samples. More than 96 per cent of the radioactivity was precipitable with the trichloroacetic acid, and all of the radioactivity was contained in the albumin fraction separated by electrophoresis. Radioactivity of plasma and urine samples was assayed in a well-type sodium iodide crystal. The measurements of radioactivity were related to appropriate standards.
In a number of subjects after the labeled albumin had completely disappeared from the tissue, 0.1 ml of a solution containing 10 to 15 Ac of Na24Cl or of NaI.1. was inj ected subcutaneously into an area which had previously been injected with I'3P-labeled albumin. The rate of disappearance of these radioactive ions was determined by monitoring the injection site at intervals of 1 to 3 minutes. The activity at the site of injection was corrected for background (final plateau reached after clear- .00 ance) and for decay of the isotopes. In repeat studies in cardiac patients and in all studies on paired extremities, the administered dose and volume of the radioactive ion was the same. The sites of injection were also controlled. Two types of collimation were employed to limit the detected radiation to the monitored areas. For the lower extremities, a shield of lead bricks, 2 inches thick, was constructed to provide a square opening (approximately 100 cm2) over which the injection site could conveniently be placed in front of the radiation detector, which was recessed 15 cm below the opening of the shield. For monitoring the thyroid gland and the injection site in the upper extremities, a conical lead shield, 2 inches thick, with a round opening (approximately 175 cm') into which the radiation detector was recessed 40 cm, was used.
Duplicate determinations of the monitored radioactivity checked within 2 per cent. Tissue background radiation arising from circulating P1'-albumin at the injection site was assumed to be equal to that of a similar area in the opposite extremity.
RESULTS
The results are summarized in Tables I through  VII. Removal of I131-albumin from the normal limb. The disappearance rate of injected labeled albumin from the subcutaneous tissue of a normal leg is illustrated in Figure 1 . For the first 4 to 8 hours following the injection of I1"'-albumin there was a relatively rapid decrease in radioactivity over the injected area in 10 of the 15 cases. During this period 10 to 28 per cent of the injected dose disappeared. Thereafter the radioactivity decreased more slowly. The half-time of disappearance (Ti), calculated from the slower exponential component of the disappearance curve, averaged 33.4 hours and ranged from 18 to 48 hours. In contrast to these values, the T4 of NaI131 from the subcutaneous tissue of the same subjects averaged 11.9 minutes and ranged from 7 to 18 minutes. There was no consistent relationship between the T1 of I'31-labeled albumin and that of NaIl31.
Repeated scanning over the site of injection revealed that I131-albumin remained within the monitored area, although some diffusion occurred. Immediately after injection, the area occupied by the injected activity averaged about 3.8 cm2, whereas 24 and 48 hours after the injection it averaged 11.3 and 13.6 cm2, respectively. The relationship between the T1 and the area of diffusion of the .s 4) . o 20 .
.. injected activity was inconsistent. Scans of the crease of radioactivity over the regional lymph limbs also showed that the radioactivity through-nodes. out the injected limb, except for the injection site, As I131-albumin disappeared from the site of was comparable to that in the opposite control injection, the radioactivity in the blood increased limb and was not accompanied by a detectable in-progressively in the first 18 to 36 hours and reached a plateau in 48 to 72 hours. The buildup of radioactivity in the plasma was more rapid in those subjects with a short than in those with a long T4 of 1131-labeled albumin. Of the total activity in each plasma sample, more than 96 per cent was contained on the protein fraction precipitated by 10 per cent trichloroacetic acid.
Thyroid and urine radioactivities averaged, respectively, 1.9 and 4.3 per cent of the injected dose per day.
Removal of I131-alblinmin from the lymnphedemtatous limb. The clearance of I131-albumin and NaI131 from the subcutaneous tissue of a lymphedematous limb due to a radical mastectomy and that of the opposite normal limb are compared in Figures 2 and 3 .
In six patients I131-albumin disappeared at a significantly slower rate from the lymphedematous limb than from the control limb (p < 0.01). The Tj from the involved limb averaged 101 hours and ranged from 65 to 140 hours as compared to an average of 26 hours and a range of 21 to 33 hours from the opposite normal limb. Some diffusion of the injected albumin occurred in the tissue but was not appreciably different in the two limbs. In contrast to these results, the disappearance of NaI13' and Na24Cl did not differ significantly in the lymphedematous and opposite normal limb (p > 0.9) and was approximately 150 to 600 times more rapid than the disappearance of 1131-albumin. In control studies of paired normal limbs the disappearance of labeled albumin as well as of NaI'13 and Na24Cl was approximately the same (p = 0.4 and p = 0.8, respectively).
Following the subcutaneous injection of I131-albumin, radioactivity, more than 96 per cent of which was precipitable with 10 per cent trichloroacetic acid, appeared in the plasma. The average urinary excretion of radioactivity was 2.5 per cent per day, whereas the radioactivity taken up by the thyroid gland averaged 1 per cent per day.
Remitoval of I'31-albumin in edematous limbs caused by venous occlusion. The disappearance of I131-albumin from an edematous limb caused by phlebothrombosis is compared with that of the opposite normal limb in Figure 4 .
The disappearance of I131-albumin in edema caused by venous obstruction in contrast to that caused by lymphatic obstruction was significantly increased as compared to the disappearance of 1131_ albumin in control limbs (p < 0.01). In four subjects with venous obstruction, the mean disappearance time of I131-albumin in the edematous limb was 16 hours, whereas in the opposite normal limb it was 34 hours. The diffusion of radioactivity from the subcutaneous injection site also appeared to be greater in the edematous than in the control limb. It is noteworthy that the re- activity in the subcutaneous tissue was significantly greater in the cardiac edematous than in the normal limb (p < 0.01). Twenty-four hours following injection of the I131-albumin, radioactivity of the injection site covered an average area of 22.9 cm2 in edematous cardiac patients as compared to 11.3 cm2 in normal subjects. Although the average rate of removal of Na24Cl in cardiac edema was about 50 times more rapid than that of I131-albumin, it was significantly slowed, being about one-fourth as rapid as that in normal subjects (p < 0.01).
In seven subjects who were restudied after cardiac compensation, the removal of I131-albumin from the subcutaneous tissue of the legs decreased noticeably toward the normal range. The T2 averaged 31.7 hours as compared to 13.9 hours before treatment. The clearance of Na24 also returned toward normal after treatment, but in contrast to that of 1131-albumin, it was considerably more rapid after compensation than it had been during congestive failure. The TX of Na24 before treatment averaged 53 minutes, whereas after treatment it averaged 28 minutes. The return of Na24 clearance to the normal range after treatment was associated with "complete" compensation as indicated by the disappearance of peripheral edema and a decrease in venous pressure and circulation time to normal levels. However, normal clearance values for I131-albumin occurred without "complete" compensation, but it was consistently associated with the disappearance of edema.
Removal of I'31-albumnin in hypoproteinemic edema. The disappearance of I131-albumin from the subcutaneous tissue of the legs of patients with hypoproteinemic edema caused by cirrhosis or nephrotic syndrome was significantly more rapid than that in the control group (p < 0.01). The T, averaged 15.2 hours and ranged from 10 to 20 hours. DISCUSSION I131-albumin appeared to have a high degree of stability following injection into the subcutaneous tissue. The existence of a firm bond between the radioiodine and albumin molecules in the tissue is supported by the observation that the disappearance of I131-albumin from the tissues was considerably slower than that of inorganic 1131. The amount of radioiodine excreted in the urine and taken up by the thyroid gland following the subcutaneous injection of the labeled albumin was small and consistent with the metabolic breakdown of plasma proteins, and over 96 per cent of the plasma radioactivity was contained on the protein fraction precipitated by trichloroacetic acid and was accounted for in the albumin fraction separated by electrophoresis.
The removal of labeled albumin from the resting limb was slow but occurred at an exponential rate. The explanation for the increased clearance of the labeled protein in the first 4 to 8 hours after injection is not clear but might be due to the injection of some radioactivity directly into the subcutantous lymphatic capillaries or to a temporary injury to the lymphatic capillaries by the injection. Some dissociation of 1131 from the albumin molecule has been reported to occur in certain batches of radioiodinated serum albumin (16) . However, it is unlikely that the clearance of unbound 1131 would account for the relatively rapid fall-off of activity at the injection site during the first 4 or more hours, since the removal of inorganic J131 was virtually complete in 1 hour.
The appearance of radioactivity in the blood did not parallel the disappearance of radioactivity from the site of injection even when appropriate corrections were made for the radioactivity which had been excreted in the urine or taken up by the thyroid gland. The dissimilarities in the disappearance and appearance curves are not surprising, since the level of radioactivity in the blood at a given time presumably is influenced not only by the amount of radioactivity appearing in the blood from the injection site but also by the volume of distribution of the radioactivity, which increases as the labeled albumin equilibrates with extravascular protein.
The marked reduction in the clearance of J131_ albumin from the subcutaneous tissue in lymphedema suggests that the principal route of removal of extravascular protein in man is through the lymphatic vessels and that the direct passage of interstitial protein across blood capillaries into the blood stream is negligible in such a limb. Studies with I131-albumin in animals also support this view (17) . The finding also suggests that the rate of disappearance of labeled albumin might be employed as an index of lymphatic "function." including flow, since it is likely that protein is ab-sorbed by the lymphatic vessels along with a relatively fixed amount of interstitial fluid. In animal studies, Drinker and Field have concluded that the absorption of protein by the lymphatics is accompanied'by salt and water in the same concentrations that exist in the tissue fluid (1) .
The present observations that the disappearance of Na24 or 1131 from subcutaneous tissue is much more rapid that that of I131-albumin, that it is comparable in lymphedematous and normal limbs, and that it is influenced by the degree of cardiac compensation, are in line with the evidence that inorganic ions are principally cleared from the interstitial fluid by direct diffusion through the blood capillaries into the blood stream (18) (19) (20) (21) . The findings are also consistent with reports that the rate of disappearance of inorganic ions from the tissues may be a useful index of blood flow, especially through the capillaries (18) (19) (20) .
With the exception of lymphatic edema, the disappearance of J'31-albumin in edema caused by other conditions such as venous obstruction, congestive heart failure, and hypoproteinemia was significantly more rapid than the removal of J131. albumin from normal limbs. It is unlikely that the differences in albumin removal were due to differences of diffusion of the injected protein in the subcutaneous tissue, since the IP1"-albumin disappeared at an exponential rate. It is also improbable that differences shown by the different groups in thyroidal and renal clearances of radioiodide liberated from degraded 1131-albumin influenced the disappearance of the injected albumin.
An increase in permeability to protein in the blood capillaries might also promote the removal of I131-albumin by the blood stream. However, evidence for such a change is lacking in cardiac and nephritic edema, since the interstitial protein concentration in these conditions is only a small fraction of the plasma protein concentration and no greater than the protein content of interstitial fluid in normal limbs (22, 23) . Furthermore, Ross and Walker have recently presented findings which indicate a decrease rather'than an increase in capillary permeability to protein in congestive heart failure (24) . Other present observations which argue against the blood stream as the major route of removal of subcutaneously injected albumin in cardiac edema are those showing that the clearance of I131-albumnin changed in an opposite direction to that of NaI131 or Na24Cl following recovery from heart failure.
These results are consistent with the presence of an increased lymphatic flow in cardiac edema. They also appear to indicate that edema fluid in heart failure is not "stagnant," but actually exchanges with the fluid and salt in the blood and circulates through the lymphatics at a fairly constant rate and more rapidly than does normal interstitial fluid.
As opposed to the present findings, McMaster has concluded from the local spread of vital dyes injected intradermally that lymphatic flow, although increased in nephritic edema, was negligible or absent in cardiac edema (10). Threefoot, using similar methods of study, has indicated a reduction in lymphatic flow within the skin of all edematous extremities (11) . Since leakage of the vital dye from the cutaneous lymphatics was reported to occur in both these studies, it might have influenced the results of the experiments. Furthermore, the interpretation of these studies was made from the distribution and not from the actual rate of removal of the dye from the tissues.
In addition to the methods of measurement, other factors which might account for differences in results between those and the present studies include the age of the patients studied, duration of the edema, and differences in the cutaneous as compared with the subcutaneous lymphatic flow. In the current study the patients were younger and had a shorter history of heart failure than the patients studied by McMaster.
In edema, especially of long duration, a proliferation of interstitial tissue may occur and interfere with lymphatic drainage. This factor and differences in interstitial pressure may account for the variations in the clearance of labeled albumin from edematous tissues. It likewise appears from the observations in edematous states, especially in heart failure and superior vena caval block syndrome, that the interstitial pressure is an extremely important determinant of lymphatic flow, even when marked hypertension exists in the veins into which the main lymphatics drain.
SUM MARY
The disappearance of human serum albumin labeled with radioiodine from the subcutaneous 232 LYMPHATIC FLOW IN HUMAN SUBJECTS WITH AND WITHOUT EDEMA tissue of the forearm or leg described an exponential slope and was followed by the appearance of radioactive albumin in the blood. The rate of removal of 1131-albumin from the tissues was significantly reduced in edema caused by lymphatic obstruction, but significantly increased in edema caused by venous obstruction, congestive heart failure or hypoproteinemia. The disappearance of Na24Cl or of NaJ131 from the tissues was considerably more rapid than that of I131-albumin and was not significantly altered in lymphatic edema, although it was significantly reduced in cardiac edema. Following treatment of the heart failure, the clearance of labeled protein and inorganic ions changed in opposite directions and returned to or toward normal values.
These findings indicate that 1131-albumin injected into the subcutaneous tissue is removed mainly by lymphatic vessels and suggest that lymphatic flow is reduced in lymphedema but is increased in cardiac and other types of edema.
